Dyspepsia, Hepatic Steatosis and Renal Microlithiasis: A Case Comprehensive Clinic.

Dyspepsia, Hepatic Steatosis and Renal Microlithiasis: A Comprehensive Clinical Case

Authors

  • Soraya Rita Sousa Ribeiro Facultad de Ciencias de la Salud, Universidad Central del Paraguay.
  • Ingrid Camila Melgarejo Ferreira Facultad de Ciencias de la Salud, Universidad Central del Paraguay. https://orcid.org/0009-0009-3525-299X

Keywords:

Dispepsia, esteatosis hepática, microlitiasis renal

Abstract

SUMMARY: Dyspepsia, commonly known as indigestion, is a term that describes a set of symptoms focused on pain or discomfort in the upper abdomen and affects approximately 21% of the population, although only a small percentage seek medical assistance. It is classified as functional when no organic cause is found after adequate clinical evaluation, which occurs in up to 70% of cases. In the case under study, a 43-year-old man came to the clinic due to acute epigastric pain, a cardinal symptom of dyspepsia, accompanied by episodes of nausea without irradiation of the pain and without systemic signs such as fever. Following the diagnosis of dyspepsia and hepatic steatosis, therapeutic management included Sertal compound, a drug used to treat gastrointestinal spasms, and diet, focusing on fat reduction, which is consistent with the literature suggesting that dietary modifications and lifestyle can alleviate symptoms. Laboratory tests revealed hypertriglyceridemia and an elevated level of the ALT enzyme, suggesting liver impairment, although blood count and kidney function were within normal ranges. Abdominal ultrasound revealed bilateral renal microlithiasis and hepatic steatosis, supporting the initial diagnosis and underlining the importance of regular follow-up, in this case, quarterly, to evaluate the patient's progress and the effectiveness of the prescribed treatment.

Downloads

Download data is not yet available.

Author Biographies

Soraya Rita Sousa Ribeiro, Facultad de Ciencias de la Salud, Universidad Central del Paraguay.

Estudiante de la carrera de medicina de la Facultad de Ciencias de la Salud, Universidad Central del Paraguay.

Ingrid Camila Melgarejo Ferreira, Facultad de Ciencias de la Salud, Universidad Central del Paraguay.

Médica, docente de la carrera de medicina de la Facultad de Ciencias de la Salud, Universidad Central del Paraguay.

References

(1) MPG Journal. Epidemiología, caracte-rísticas clínicas y asociación de síntomas Ro-ma IV en dispepsia funcional [Internet]. mpgjournal.mpg.es. [citado el 7 de noviem-bre de 2023]. Disponible en: mpgjour-nal.mpg.es.

(2) PubMed. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a sys-tematic review [Internet]. pub-med.ncbi.nlm.nih.gov. [citadoel 7 de noviembre de 2023]. Disponible en: pub-med.ncbi.nlm.nih.gov.

(3) PubMed. Kidney stones: a global pic-ture of prevalence, incidence, and associated risk factors [Internet]. pub-med.ncbi.nlm.nih.gov. [citadoel 7 de noviembre de 2023]. Disponible en: pub-med.ncbi.nlm.nih.gov.

(4) American GastroenterologicalAssocia-tion. Guía de la AGA sobre el manejo inicial de la dispepsia. Gastroenterology. 2020;158(4):769-7821.

(5) European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388-14022.

(6) National Institute for Health and Care Excellence. NICE Guideline [NG184]: Renal and ureteric stones: assessment and man-agement. London: NICE; 20213

(7) García-Compeán D, González-González JA, Lavalle-González FJ, et al. Eco-grafía, técnica diagnóstica en esteatosis he-pática no alcohólica. RevGastroenterol Mex. 2016;81(1):41-50.

(8) Cohen DE, Lavine JE. Guía de diag-nóstico y tratamiento del hígado graso no alcohólico. Acta GastroenterolLatinoam. 2017;47(1):60-74.

(9) Santolaria F, Pérez-Ramírez A, Milena A, et al. Dispepsia, pancreatitis crónica y es-teatosis pancreática. RevEspEnfermDig. 2012;104(1):9-17.

(10) Machado MV, Cortez-Pinto H. Diag-nóstico de esteatosis hepática por métodos clínicos, bioquímicos y de imagen. Gastroen-terolHepatol. 2011;34(9):607-15.

(11) Chalasani N, Younossi Z, Lavine JE, et al. Hígadograso no alcohólico (esteatohepa-titis no alcohólica, NAFLD). En: Post TW, ed. Manual MSD versión para profesionales. Ke-nilworth, NJ: Merck Sharp &Dohme Corp.; 2018.

(12) Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG Clinical Guideline: Man-agement of Dyspepsia. Am J Gastroenterol. 2017;112(7):988-1013.

(13) Cheung KS, Chan EW, Wong AYS, et al. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. 2018;67(1):28-35.

(14) Gambaro G, Croppi E, Coe F, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29(6):715-34.

Published

2024-09-13

How to Cite

Sousa Ribeiro, S. R., & Melgarejo Ferreira, I. C. . (2024). Dyspepsia, Hepatic Steatosis and Renal Microlithiasis: A Case Comprehensive Clinic.: Dyspepsia, Hepatic Steatosis and Renal Microlithiasis: A Comprehensive Clinical Case. Revista MEDUCP, 1(1), 111–117. Retrieved from https://revistapjc.central.edu.py/index.php/epicentro/article/view/102